Related Experiment Videos
Abstract:
Cervicofacial actinomycosis is a disease that is currently encountered as a pseudotumor entity or cold abscess. The frequent use of antibiotics in treatment of masses in the cervicofacial region may either delay its appearance or disguise the diagnosis. The surgeon must be highly suspicious when making the diagnosis since precautions in handling the biopsy specimens are necessary. Treatment consists of incision biopsy and drainage or aspiration to establish the diagnosis, followed by prolonged penicillin therapy. In those patients allergic to penicillin, clindamycin should be the initial drug of choice. Either medication must be administered for a prolonged period of time, even after the disease is clinically controlled.
Insights
Cervicofacial actinomycosis, a pseudotumor entity, is often masked by antibiotic use. Early surgical diagnosis and prolonged penicillin or clindamycin therapy are crucial for effective treatment.
Area of Science:
- Infectious Diseases
- Surgical Pathology
- Microbiology
Background:
- Cervicofacial actinomycosis presents as a pseudotumor or cold abscess.
- Antibiotic use can delay or obscure diagnosis of cervicofacial masses.
Observation:
- Surgeons require high suspicion for diagnosis.
- Handling biopsy specimens necessitates specific precautions.
Findings:
- Diagnosis is established via incision biopsy, drainage, or aspiration.
- Prolonged penicillin therapy is the primary treatment.
- Clindamycin is the alternative for penicillin-allergic patients.
Implications:
- Prompt diagnosis and appropriate antibiotic selection are vital.
- Extended treatment duration is necessary for complete disease control.